Elizabeth Nunn, Natasha Jaiswal, Matthew Gavin, Kahealani Uehara, Megan Stefkovich, Karima Drareni, . . . Paul M. Titchenell. (2024). Antibody blockade of activin type II receptors preserves skeletal muscle mass and enhances fat loss during GLP-1 receptor agonism. Elsevier.
Chicago Style (17th ed.) CitationElizabeth Nunn, et al. Antibody Blockade of Activin Type II Receptors Preserves Skeletal Muscle Mass and Enhances Fat Loss During GLP-1 Receptor Agonism. Elsevier, 2024.
MLA (9th ed.) CitationElizabeth Nunn, et al. Antibody Blockade of Activin Type II Receptors Preserves Skeletal Muscle Mass and Enhances Fat Loss During GLP-1 Receptor Agonism. Elsevier, 2024.
Warning: These citations may not always be 100% accurate.